RHAMNOFIT
Food for Medical Purposes, Nutraceuticals
Information
RHAMNOFIT
Patented Probiotic Oil Drops with Lactobacillus rhamnosus GG ATCC 53103
Rhamnofit is an advanced probiotic formulated as oral drops, based on the patented strain Lactobacillus rhamnosus GG ATCC 53103, combined with zinc.
L. rhamnosus GG ATCC 53103 is one of the most clinically documented probiotic strains worldwide. It is supported by extensive scientific evidence for intestinal microbiota restoration, reduction of acute and antibiotic associated diarrhea, and support of gut and immune function, particularly in pediatric populations.
Rhamnofit delivers 5 billion CFU per milliliter in a liquid oil based format, ensuring high stability, precise dosing and optimal compliance.
The drop formulation allows flexible administration, directly or mixed with liquids, without compromising probiotic viability.
Rhamnofit is designed to rapidly rebalance intestinal flora in cases of rotavirus diarrhea, antibiotic induced gastrointestinal disorders and microbiota disruption.
The addition of zinc contributes to immune support and intestinal barrier function.
Key differentiators
Patented Lactobacillus rhamnosus GG ATCC 53103 strain.
Liquid oil based probiotic, technically complex and rare.
Clinically supported indications.
Pediatric friendly dosing.
Clean label and export ready.
This product reflects KSMC Laboratories’ expertise in probiotic science, strain selection, stabilization and advanced liquid nutraceutical formulation.
